Effect of Vestibular Rehabilitation - a Randomized Controlled Trial

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT00702832
Collaborator
Haukeland University Hospital (Other), St. Olavs Hospital (Other)
54
1
2
47
1.1

Study Details

Study Description

Brief Summary

The aim of this study is to assess if early supported vestibular rehabilitation can reduce dizziness and improve daily life activities in patients with acute vestibular injury.

The study question is: Does early supported vestibular rehabilitation have an additional effect on dizziness symptoms and daily life functions compared to standard treatment?

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Vestibular rehabilitation
  • Other: standard treatment
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of Vestibular Rehabilitation in the Treatment of Patients With Acute Vestibular Loss. - A Randomized Controlled Trial
Actual Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Dec 1, 2011
Actual Study Completion Date :
Dec 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vestibular rehabilitation

early supported vestibular rehabilitation

Behavioral: Vestibular rehabilitation
Daily home training (4-6 specific exercises) 2-3 times per day. Group training led by a physiotherapist twice per week during the first 10 weeks and once per week from 10 weeks to 12 months or to symptoms are cured.

Active Comparator: standard

standard treatment

Other: standard treatment
treatment as usual

Outcome Measures

Primary Outcome Measures

  1. vertigo [at inclusion, 10-12 weeks, 12 months]

    Vertigo symptom scale (VSS)

Secondary Outcome Measures

  1. Dizziness [At inclusion, 10-12 weeks, 12 months]

    Dizziness Handicap Inventory (DHI), University of California Los Angeles Dizziness Questionnaire (UCLA-DQ), Three questions regarding dizziness on VAS-scale,

  2. Movement provoked dizziness [at inclusion, 10-12 weeks, 12 months]

    Rombergs test and advanced Rombergs test

  3. return of symptoms [12 months]

  4. sick leave [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • acute symptoms of dizziness, nausea and nystagmus

  • diagnosed by videonystagmography (at least 25% reduced caloric response in one ear)

  • age 18-70 years

  • inclusion within one week after symptom debut

Exclusion Criteria:
  • chronic dizziness

  • psychiatric diagnosis that might interfere with participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 St. Olavs Hospital Trondheim Norway 7489

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • Haukeland University Hospital
  • St. Olavs Hospital

Investigators

  • Principal Investigator: Siv Mørkved, PhD, Associate professor / senior researcher

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00702832
Other Study ID Numbers:
  • REK 4.2007.1802
First Posted:
Jun 20, 2008
Last Update Posted:
Dec 9, 2019
Last Verified:
Dec 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 9, 2019